Bilateral polymicrogyria as the indicative feature in a child with a 22q11.2 deletion
Erica H Gerkes1, Roel Hordijk, Trijnie Dijkhuizen
1Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Insights
Polymicrogyria (PMG), a brain malformation, is linked to 22q11.2 deletion syndrome. Investigating PMG for 22q11.2 deletion is crucial, even without typical velocardiofacial syndrome features.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Polymicrogyria (PMG) is a cortical malformation characterized by abnormal brain organization.
- PMG is a heterogeneous disorder, notably associated with 22q11.2 deletion syndrome (velocardiofacial syndrome).
- The association between PMG and 22q11.2 deletion was first identified in 1996, with over 30 cases reported.
Observation:
- In 22q11.2 deletion syndrome, PMG predominantly affects perisylvian areas, often asymmetrically with a right hemisphere predisposition.
- Neurological manifestations include developmental delay, seizures, microcephaly, spasticity, and oromotor dysfunction.
- A case is presented of a seven-month-old boy with microcephaly, short stature, and developmental delay, exhibiting symmetrical perisylvian PMG and a confirmed 22q11.2 deletion.
Findings:
- The patient lacked other common features of velocardiofacial syndrome, highlighting atypical presentations.
- Array-based comparative genomic hybridization confirmed the 22q11.2 deletion.
- PMG, particularly in perisylvian regions, was the primary indicator in this case.
Implications:
- The presence of PMG, especially perisylvian PMG, warrants investigation for 22q11.2 deletion in pediatric patients.
- This finding has significant prognostic value for children diagnosed with 22q11.2 deletion syndrome.
- Clinicians should consider 22q11.2 deletion testing even when typical velocardiofacial syndrome symptoms are absent.
Abstract:
Polymicrogyria (PMG) is a brain malformation due to abnormal cortical organisation. It is a heterogeneous disorder associated with 22q11.2 deletion syndrome (also known as velocardiofacial (VCF) syndrome) amongst others. Since this association was first recognised in 1996, over 30 patients with PMG and 22q11.2 deletion have been described. In 22q11.2 deletion syndrome, PMG is mainly located in the perisylvian areas; it frequently has an asymmetrical presentation with a striking predisposition for the right hemisphere. Neurological features of perisylvian PMG include developmental delay/mental retardation, seizures, microcephaly, spasticity and oromotor dysfunction. Thus in children diagnosed with 22q11.2 deletion syndrome, a finding of PMG has important prognostic value. We present a seven-month old boy with microcephaly, short stature and developmental delay. A cerebral MRI showed slightly enlarged ventricles and symmetrical perisylvian polymicrogyria. A 22q11.2 deletion was revealed by array-based comparative genomic hybridization. Remarkably the boy had no other manifestations of VCF syndrome. Paediatricians, child neurologists and clinical geneticists should be aware that the presence of PMG (especially in the perisylvian areas) needs investigating for 22q11.2 deletion, even if other more common VCF syndrome features are absent.
More Related Videos
09:16Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
06:04Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
Published on: August 16, 2024
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Karyotyping
Meiosis I
Pleiotropy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
